Using human acellular dermal matrix for treating pelvic organ prolapse in women
Official title: Transvaginal Human Acellular Dermal Matrix and Sacrospinous Fixation for Anterior and Apical Prolapse Treatment in Patients With Hiatal Ballooning or Levator Ani Injury: a Randomized Pilot Trial
Run by Hospital Mutua de Terrassa · NCT06404931 · Data updated 2026-11-12
This study is testing three different surgical options to see which one works best for women with pelvic organ prolapse.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 100 Years |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Hospital Mutua de Terrassa Academic / other |
| Locations | 1 site (Terrassa) |
| Status | Recruiting |
| Started | July 1, 2024 |
| Main results expected | January 1, 2025 |
| Study ends | January 1, 2026 |
| Registry record updated | January 17, 2025 |
| Trial ID | NCT06404931 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women over 18 with symptomatic anterior and apical prolapse who are eligible for vaginal surgical treatment.
✕Probably not a fit
Patients with previous pelvic floor surgery, chronic pelvic pain, or advanced prolapse (grade IV) may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of three surgical procedures for treating symptomatic anterior and apical prolapse in women. Participants will be randomly assigned to one of three groups: one receiving a classic vaginal hysterectomy with anterior colporrhaphy, another receiving a vaginal hysterectomy with human acellular dermal matrix reinforcement, and the last receiving vaginal hysterectomy with sacrospinous fixation alone. The study will assess anatomical severity and symptoms using validated questionnaires and 3D ultrasound imaging, with follow-ups scheduled at multiple intervals over three years to monitor outcomes and complications.
Why it matters
Potential benefit: If successful, this study could provide a more effective surgical option for women suffering from pelvic organ prolapse.
How similar studies have gone: Other studies have shown promise in using acellular dermal matrices for surgical reinforcement, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with symptomatic POP with indication of vaginal surgery. * Women with hiatal ballooning or levator ani injury evaluated by 3D pelvic floor ultrasound. * Women ≥18 years old. * Women wishing to complete a 36-month follow-up. * Understand and accept the study procedures and sign the informed consent. Exclusion Criteria: * Women with previous pelvic floor or prolapse surgery * Women with POP grade IV * Women with chronic pelvic pain. * Not being able to understand the nature of the study and/or the procedures to be followed. * Not signing the informed consent
Where it's running
-
Hospital Mutua de Terrassa
Terrassa, Spain Recruiting
Study contacts
- Study coordinator: Gerard Molina
- Phone: +34937365050
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluation of the Anchorsure® Device for Treating Apical Prolapse in Women
This study is testing a new device called Anchorsure® to see if it can help women with pelvic organ prolapse have a quicker and less painful surgery while keeping everything securely in place.
-
Comparing biological and synthetic mesh in pelvic prolapse surgery
This study is testing whether a new biological mesh works better than the standard synthetic mesh in surgeries for pelvic prolapse to help doctors make better choices for their patients.
-
Exploring the connection between the jaw joint and pelvis in women with certain health issues
This study is testing if a special therapy can help women with prolapse and endometriosis-related pain by looking at how the jaw joint and pelvis are connected.
-
Plan B and heart health: a look at how a single dose affects veins and arteries in young women
This study tests whether a single dose of Plan B® affects the blood vessels and heart health of healthy premenopausal women aged 18-35, by comparing it to a placebo in a short-term, double-blind setup.
-
Probiotic mix to see if it boosts fullness in adults who are overweight or have obesity
A probiotic supplement is being tested in adults aged 20-70 who are overweight or have obesity to see if it makes them feel fuller and changes gut bacteria harder after 16 weeks, compared with a placebo.
-
Fluorocholine PET/MR imaging in breast cancer patients before treatment
This study tests whether pre-treatment FCH PET/MR imaging markers can help predict breast cancer subtypes and likely outcomes in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.